Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Yee

Showing results (71-80 of 73) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 73 results.
Nature Communications|July 2, 2024
A chemogenetic approach for dopamine imaging with tunable sensitivityMarie A Labouesse, Maria Wilhelm, Zacharoula Kagiampaki, et al.
Nature Methods|February 26, 2026
Next-generation multicolor indicators for in vivo imaging of norepinephrineValentin Lu Rohner, Sebastiano Curreli, Paul J Lamothe-Molina, et al.
Science Translational Medicine|September 3, 2025
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancerKathleen M McAndrews, Francesca Paradiso, Clint A Stalnecker, et al.
Pageof 8

Showing results (71-80 of 73) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 73 results.
Nature Communications|July 2, 2024
A chemogenetic approach for dopamine imaging with tunable sensitivityMarie A Labouesse, Maria Wilhelm, Zacharoula Kagiampaki, et al.
Nature Methods|February 26, 2026
Next-generation multicolor indicators for in vivo imaging of norepinephrineValentin Lu Rohner, Sebastiano Curreli, Paul J Lamothe-Molina, et al.
Science Translational Medicine|September 3, 2025
An allele-agnostic mutant-KRAS inhibitor suppresses tumor maintenance signals and reprograms tumor immunity in pancreatic cancerKathleen M McAndrews, Francesca Paradiso, Clint A Stalnecker, et al.
Pageof 8